These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 19444722)

  • 21. Physicians practicing in methadone treatment programs: who are they and what do they do?
    Wechsberg WM; Flannery B; Kasten JJ; Suerken C; Dunlap L; Roussel AE; Crum L; Murdoch O; Diesenhaus H
    J Addict Dis; 2004; 23(2):15-31. PubMed ID: 15132340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A special type of 'hard-to-reach' patient: experiences of pregnant women on methadone.
    Calvin C; Moriarty H
    J Prim Health Care; 2010 Mar; 2(1):61-9. PubMed ID: 20690404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The experience of chronic severe pain in patients undergoing methadone maintenance treatment.
    Karasz A; Zallman L; Berg K; Gourevitch M; Selwyn P; Arnsten JH
    J Pain Symptom Manage; 2004 Nov; 28(5):517-25. PubMed ID: 15504628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. User views on supervised methadone consumption.
    Stone E; Fletcher K
    Addict Biol; 2003 Mar; 8(1):45-8. PubMed ID: 12745415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dealing with aggressive methadone patients in community pharmacy: a critical incident study.
    Irwin A; Laing C; Mearns K
    Res Social Adm Pharm; 2012; 8(6):542-51. PubMed ID: 22381914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substance, structure and stigma: parents in the UK accounting for opioid substitution therapy during the antenatal and postnatal periods.
    Chandler A; Whittaker A; Cunningham-Burley S; Williams N; McGorm K; Mathews G
    Int J Drug Policy; 2013 Nov; 24(6):e35-42. PubMed ID: 23688832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BDNF variability in opioid addicts and response to methadone treatment: preliminary findings.
    de Cid R; Fonseca F; Gratacòs M; Gutierrez F; Martín-Santos R; Estivill X; Torrens M
    Genes Brain Behav; 2008 Jul; 7(5):515-22. PubMed ID: 18182069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proportional hazards frailty models for recurrent methadone maintenance treatment.
    Nosyk B; MacNab YC; Sun H; Fischer B; Marsh DC; Schechter MT; Anis AH
    Am J Epidemiol; 2009 Sep; 170(6):783-92. PubMed ID: 19671835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of methadone program non-retention for opioid analgesic dependent patients.
    Cox J; Allard R; Maurais E; Haley N; Small C
    J Subst Abuse Treat; 2013 Jan; 44(1):52-60. PubMed ID: 22538172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methadone maintenance expands inside federal prisons.
    Sibbald B
    CMAJ; 2002 Nov; 167(10):1154. PubMed ID: 12427715
    [No Abstract]   [Full Text] [Related]  

  • 31. Reducing stigma through education to enhance Medication-Assisted Recovery.
    Woods JS; Joseph H
    J Addict Dis; 2012; 31(3):226-35. PubMed ID: 22873184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sociodemographic Profiles and Clinical Outcomes for Clients on Methadone Maintenance Treatment in a Western Canadian Clinic: Implications for Practice.
    Maina G; Crizzle A; Maposa S; Fournier B
    J Forensic Nurs; 2019; 15(4):231-241. PubMed ID: 31764527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 'Crisis' and 'everyday' initiators: A qualitative study of coercion and agency in the context of methadone maintenance treatment initiation.
    Damon W; Small W; Anderson S; Maher L; Wood E; Kerr T; McNeil R
    Drug Alcohol Rev; 2017 Mar; 36(2):253-260. PubMed ID: 27126765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "Living with the dirty secret": problems of disclosure for methadone maintenance clients.
    Murphy S; Irwin J
    J Psychoactive Drugs; 1992; 24(3):257-64. PubMed ID: 1432404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Community pharmacy harm reduction services for drug misusers: national service delivery and professional attitude development over a decade in Scotland.
    Matheson C; Bond CM; Tinelli M
    J Public Health (Oxf); 2007 Dec; 29(4):350-7. PubMed ID: 17986490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opiate users' perceived barriers against attending methadone maintenance therapy: a qualitative study in China.
    Lin C; Wu Z; Detels R
    Subst Use Misuse; 2011; 46(9):1190-8. PubMed ID: 21417558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preference for sweet foods and higher body mass index in patients being treated in long-term methadone maintenance.
    Nolan LJ; Scagnelli LM
    Subst Use Misuse; 2007; 42(10):1555-66. PubMed ID: 17918026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized, open-label trial comparing methadone and Levo-Alpha-Acetylmethadol (LAAM) in maintenance treatment of opioid addiction.
    Wolstein J; Gastpar M; Finkbeiner T; Heinrich C; Heitkamp R; Poehlke T; Scherbaum N
    Pharmacopsychiatry; 2009 Jan; 42(1):1-8. PubMed ID: 19153939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A preventive ethics approach to methadone maintenance programmes.
    Townshend PL; Sellman JD; Coverdale JH
    N Z Bioeth J; 2001 Oct; 2(3):7-13. PubMed ID: 15587001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Risk factors associated with continued heroin use during methadone maintenance treatment in Guizhou province, China].
    Liu EW; Wu ZY; Liang T; Shen LM; Zhong H; Wang B; Roger D
    Zhonghua Yu Fang Yi Xue Za Zhi; 2008 Dec; 42(12):875-8. PubMed ID: 19141219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.